New research has found that at-home gut microbiome tests lack standardization, resulting in different results from the same stool sample.
Researchers develop nasal “universal vaccine” that shields mice from viruses, bacteria and allergens
Stanford Medicine researchers developed a nasal spray vaccine that protected mice against viruses, bacteria and allergens — a ...
New clinical focus explores the connection between vagus nerve dysfunction, toxic burden, hidden pathogens, and early ...
The FDA has cleared a multiplex polymerase chain reaction test designed to detect 11 clinically relevant gastrointestinal pathogens from a single stool sample.The Xpert GI Panel (Cepheid) can identify ...
Our mission has always been clear: to eliminate contaminated food products from reaching consumers by making food ...
High-throughput neutralisation tests could lead to a better understanding of the evolution of human influenza.
Most bacterial gastrointestinal illnesses in Australia are thought to be caused by two pathogens, Campylobacter and Salmonella. But an emerging pathogen, Aeromonas, is much more common than previously ...
A person in Vorarlberg who had contact with TB-infected animals has now tested positive for the pathogen. However, this does ...
NG Biotech and Hardy Diagnostics have received the US FDA breakthrough device designation for two rapid diagnostic assays, NG ...
The tests were developed by France's NG Biotech, which exclusively licensed their US distribution rights to Hardy.
NG Biotech, in partnership with Hardy Diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designations to two rapid diagnostic assays: ...
Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results